Marker Therapeutics Q1 2026 Earnings Loss Narrows as Clinical Progress Continues QFIN Q4 2025 Earnings EPS Misses Estimates as Stock Declines Home Sellers Question Commission Rates PostNAR Settlement Will the 6 Standard Shift China Prepares Humanoid Robots for Employment as Part of Industrial Strategy GRND Q4 2025 Earnings EPS Miss Amid Flat Revenue Disclosure Stock Slips Green Brick Partners Inc GRBK Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response Savara Inc SVRA Q1 2026 Earnings WiderthanExpected Loss Highlights DevelopmentStage Costs